Streetbeat News

Regulatory

BA

The National Transportation Safety Board (NTSB) has sanctioned Boeing for releasing details of the 737 MAX 9 investigation prematurely. This action could impact Boeing's reputation and investor confidence.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 9:32 am

IBKR

SPY

Interactive Brokers' Thomas Peterffy announced that the CFTC will not allow election-related contracts on their new prediction market, ForecastEx, due to concerns about potential election influence. ForecastEx will launch on July 8, offering contracts on economic and climate indicators. The CFTC's decision follows a vote to reject event contracts based on political activity to protect U.S. customers.

Portfolio Pulse from Benzinga Neuro

June 27, 2024 | 8:21 am

MRK

The FDA has issued a Complete Response Letter (CRL) for the Biologics License Application (BLA) of Daiichi Sankyo and Merck's lung cancer treatment, patritumab deruxtecan, due to third-party manufacturing concerns. The CRL did not identify any issues with the efficacy or safety data submitted.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 7:13 am

JPM

JPMorgan Chase & Co. has reviewed the Federal Reserve's 2024 stress test results and identified potential discrepancies in the projections for Other Comprehensive Income (OCI). The firm believes the benefit in OCI may be overstated, which could result in modestly higher stress losses than disclosed. As of March 31, 2024, JPMorgan Chase reported a CET1 capital ratio of 15.0%, significantly above the regulatory requirement of 11.9%.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 7:08 am

GMAB

Genmab announced that the U.S. FDA approved EPKINLY for the treatment of adults with relapsed or refractory follicular lymphoma after two or more lines of systemic therapy.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 6:54 am

ABBV

AbbVie announced that the U.S. FDA has approved EPKINLY as the first and only T-cell engaging bispecific antibody administered subcutaneously for the treatment of adults with relapsed or refractory follicular lymphoma.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 6:50 am

NVX

NOVONIX Limited announced it has been granted a patent for its proprietary all-dry, zero-waste cathode synthesis technology in Japan. This development could enhance NOVONIX's competitive edge in the battery materials market.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 6:46 am

BTCUSD

ETHUSD

IDCBF

Indonesia has experienced a significant cyberattack by the LockBit ransomware gang, affecting over 40 government entities, including major airports and immigration services. The attackers demanded an $8 million ransom in Bitcoin and Ethereum, which the government refused to pay. Efforts are ongoing to restore data at affected agencies.

Portfolio Pulse from Aniket Verma

June 27, 2024 | 5:25 am

BA

SPR

Boeing has refuted claims that NASA astronauts are stranded on its Starliner spacecraft, despite a delayed return from the ISS. The delay comes amid ongoing safety controversies for Boeing, including scrutiny over its 737 Max aircraft. Boeing's proposed acquisition of Spirit Aerosystems is seen as a positive move for recovery.

Portfolio Pulse from Benzinga Neuro

June 27, 2024 | 3:47 am

GBTC

HODL

IBIT

The SEC is expected to approve Ethereum spot ETFs by July 4, following successful Bitcoin spot ETFs. Asset managers like BlackRock, VanEck, and Grayscale are involved. Analysts predict a less impressive launch for Ethereum ETFs due to its smaller market cap and trading volumes.

Portfolio Pulse from Aniket Verma

June 27, 2024 | 3:09 am